247 related articles for article (PubMed ID: 31245934)
1. Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction.
Xu J; Xiong YY; Li Q; Hu MJ; Huang PS; Xu JY; Tian XQ; Jin C; Liu JD; Qian L; Yang YJ
Stem Cells Transl Med; 2019 Oct; 8(10):1068-1083. PubMed ID: 31245934
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19.
Huang P; Wang L; Li Q; Tian X; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Cheng K; Qian L; Yang Y
Cardiovasc Res; 2020 Feb; 116(2):353-367. PubMed ID: 31119268
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin-pretreated mesenchymal stem cell-derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA-139-3p/Stat1 pathway.
Ning Y; Huang P; Chen G; Xiong Y; Gong Z; Wu C; Xu J; Jiang W; Li X; Tang R; Zhang L; Hu M; Xu J; Xu J; Qian H; Jin C; Yang Y
BMC Med; 2023 Mar; 21(1):96. PubMed ID: 36927608
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating SDF-1/CXCR4 axis.
Tian XQ; Yang YJ; Li Q; Xu J; Huang PS; Xiong YY; Li XD; Jin C; Qi K; Jiang LP; Chen GH; Qian L; Liu J; Geng YJ
Am J Transl Res; 2019; 11(7):4214-4231. PubMed ID: 31396330
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin treatment improves the effects of mesenchymal stem cell transplantation on acute myocardial infarction: the role of the RhoA/ROCK/ERK pathway.
Zhang Q; Wang H; Yang YJ; Dong QT; Wang TJ; Qian HY; Li N; Wang XM; Jin C
Int J Cardiol; 2014 Oct; 176(3):670-9. PubMed ID: 25139321
[TBL] [Abstract][Full Text] [Related]
6. Transplantation efficacy of autologous bone marrow mesenchymal stem cells combined with atorvastatin for acute myocardial infarction (TEAM-AMI): rationale and design of a randomized, double-blind, placebo-controlled, multi-center, Phase II TEAM-AMI trial.
Xu JY; Qian HY; Huang PS; Xu J; Xiong YY; Jiang WY; Xu Y; Leng WX; Li XD; Chen GH; Tang RJ; Huang CR; Hu MJ; Jin C; Wu Y; Zhang J; Qian J; Xu B; Zhao SH; Lu MJ; Shen R; Fang W; Wu WC; Chen X; Wang Y; Li W; Lu XF; Jiang XF; Ma CC; Li JW; Geng YJ; Qiao SB; Gao RL; Yang YJ
Regen Med; 2019 Dec; 14(12):1077-1087. PubMed ID: 31829095
[No Abstract] [Full Text] [Related]
7. Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction.
Lim M; Wang W; Liang L; Han ZB; Li Z; Geng J; Zhao M; Jia H; Feng J; Wei Z; Song B; Zhang J; Li J; Liu T; Wang F; Li T; Li J; Fang Y; Gao J; Han Z
Stem Cell Res Ther; 2018 May; 9(1):129. PubMed ID: 29751831
[TBL] [Abstract][Full Text] [Related]
8. Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4.
Li N; Yang YJ; Qian HY; Li Q; Zhang Q; Li XD; Dong QT; Xu H; Song L; Zhang H
Am J Transl Res; 2015; 7(6):1058-70. PubMed ID: 26279750
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin improves the cardiac function of rats after acute myocardial infarction through ERK1/2 pathway.
Zeng HT; Zhao M; Zhang ZX; Liu ZL; Zhong SM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):7120-7127. PubMed ID: 31486514
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance.
Huang P; Wang L; Li Q; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Liu J; Qian L; Yang Y
Stem Cell Res Ther; 2019 Oct; 10(1):300. PubMed ID: 31601262
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin Pretreatment Ameliorates Mesenchymal Stem Cell Migration through miR-146a/CXCR4 Signaling.
Li N; Guo XY; Zhou J; Yan XL; Yu FF
Tissue Eng Regen Med; 2021 Oct; 18(5):863-873. PubMed ID: 34260048
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin treatment improves effects of implanted mesenchymal stem cells: meta-analysis of animal models with acute myocardial infarction.
Dai G; Xu Q; Luo R; Gao J; Chen H; Deng Y; Li Y; Wang Y; Yuan W; Wu X
BMC Cardiovasc Disord; 2015 Dec; 15():170. PubMed ID: 26667804
[TBL] [Abstract][Full Text] [Related]
13. Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway.
Yu M; Liu W; Li J; Lu J; Lu H; Jia W; Liu F
Stem Cell Res Ther; 2020 Aug; 11(1):350. PubMed ID: 32787917
[TBL] [Abstract][Full Text] [Related]
14. Sequential transplantation of exosomes and mesenchymal stem cells pretreated with a combination of hypoxia and Tongxinluo efficiently facilitates cardiac repair.
Xiong Y; Tang R; Xu J; Jiang W; Gong Z; Zhang L; Li X; Ning Y; Huang P; Xu J; Chen G; Jin C; Li X; Qian H; Yang Y
Stem Cell Res Ther; 2022 Feb; 13(1):63. PubMed ID: 35130979
[TBL] [Abstract][Full Text] [Related]
15. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
Huang B; Qian J; Ma J; Huang Z; Shen Y; Chen X; Sun A; Ge J; Chen H
Stem Cell Res Ther; 2014 Feb; 5(1):22. PubMed ID: 24507665
[TBL] [Abstract][Full Text] [Related]
16. Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats.
Tang J; Wang J; Zheng F; Kong X; Guo L; Yang J; Zhang L; Huang Y
Mol Cell Biochem; 2010 Jun; 339(1-2):107-18. PubMed ID: 20058054
[TBL] [Abstract][Full Text] [Related]
17. Marrow-derived MSCs and atorvastatin improve cardiac function in rat model of AMI.
Wang A; Shen F; Liang Y; Wang J
Int J Cardiol; 2011 Jul; 150(1):28-32. PubMed ID: 20223529
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase.
Song L; Yang YJ; Dong QT; Qian HY; Gao RL; Qiao SB; Shen R; He ZX; Lu MJ; Zhao SH; Geng YJ; Gersh BJ
PLoS One; 2013; 8(5):e65702. PubMed ID: 23741509
[TBL] [Abstract][Full Text] [Related]
19. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction.
Tang J; Wang J; Guo L; Kong X; Yang J; Zheng F; Zhang L; Huang Y
Mol Cells; 2010 Jan; 29(1):9-19. PubMed ID: 20016947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
